Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page footer shows a revision update from v3.4.0 to v3.4.1, indicating a minor software update. No user-facing content or study details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:17:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Show glossary was added to the page. The page metadata now includes 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new revision tag v3.4.0 (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T04:57:31.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Site revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:05:23.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a dedicated Locations section showing Durham, North Carolina (Duke Cancer Center) and updated the page's revision to v3.3.3. Removed the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T13:35:42.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.2 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:05:53.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Deletion of the government funding status notice that could indicate potential delays; this does not alter the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T15:04:53.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.